Skip to main content
. 2012 Apr;40(4):754–760. doi: 10.1124/dmd.111.042820

TABLE 2.

Dibenzylfluorescein O-debenzylation activities

BTC3A4_PORa kcat Km R2 kcat/Km
fluorescein-formed pmol · min1 · pmol CYP3A41 μM % WT
Null b
WT 0.43 ± 0.03 1.37 ± 0.22 0.97 0.32 (100)
P228L 0.23 ± 0.01 0.78 ± 0.14 0.95 0.30 (95)
M263V 0.28 ± 0.02 0.76 ± 0.12 0.95 0.38 (119)
A287P 0.25 ± 0.01 0.84 ± 0.10 0.97 0.29 (93)
G413S 0.33 ± 0.02 0.89 ± 0.15 0.96 0.37 (115)
Q153R 0.80 ± 0.04 4.24 ± 0.45 0.99 0.19 (60)
R457H 0.052 ± 0.001 1.70 ± 0.07 0.99 0.03 (10)
G539R 0.059 ± 0.002 0.62 ± 0.06 0.98 0.10 (30)
Y181D
Y459H
V492E
L565P
R616X
Human liver microsomes 0.47 ± 0.04 1.36 ± 0.17 0.99 0.34 (108)
a

Velocity parameters obtained using a DBF gradient up to 5 μM, except for human liver microsomes for which a gradient up to 1.25 μM was applied to prevent interference with DBF metabolism by CYP2C8 (Ghosal et al., 2003) and for CYPOR variant Q153R for which a gradient up to 10 μM was applied.

b

—, not measurable.